{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:58:26Z","timestamp":1773338306332,"version":"3.50.1"},"reference-count":55,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutical Statistics"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The estimand framework, introduced in the ICH E9 (R1) Addendum, provides a structured approach for defining precise research questions in randomised clinical trials. It suggests five strategies for addressing intercurrent events (ICE). This case study examines the principal stratum strategy, highlighting its potential for estimating causal treatment effects in specific subpopulations and the challenges involved. The occurrence of anti\u2010drug antibodies (ADAs) and their potential clinical impact are important factors in evaluating biosimilars. Typically, analyses focus on subgroups of patients who develop ADAs during the study. However, conducting subgroup analyses based on post\u2010randomisation variables, such as immunogenicity, can introduce substantial bias into treatment effect estimates and is therefore methodologically not optimal. The principal stratum strategy provides a statistical pathway for estimating treatment effects in subpopulations that cannot be anticipated at baseline. By leveraging counterfactuals to assess treatment outcomes, with and without the incidence of intercurrent events (ICEs), this approach can be implemented through a missing data perspective. We demonstrate the implementation of the principal stratum strategy in a phase 3 equivalence trial of a biosimilar for the treatment of rheumatoid arthritis. Using a multiple imputation approach, we leverage longitudinal measurements to create analysis datasets for subpopulations who develop ADAs as ICE. Our results highlight the principal stratum strategy's potential and challenges, emphasising its reliance on unobserved ICE states and the need for complex and rigorous modelling. This study contributes to a nuanced understanding and practical implementation of the principal stratum strategy within the ICH E9 (R1) framework.<\/jats:p>","DOI":"10.1002\/pst.70008","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T11:14:47Z","timestamp":1746530087000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Applying the Principal Stratum Strategy in Equivalence Trials: A Case Study"],"prefix":"10.1002","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8893-8903","authenticated-orcid":false,"given":"Jerome","family":"Sepin","sequence":"first","affiliation":[{"name":"Biogen International GmbH  Baar Switzerland"},{"name":"University of Lucerne  Lucerne Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1790-2719","authenticated-orcid":false,"given":"Thomas P. A.","family":"Debray","sequence":"additional","affiliation":[{"name":"Smart Data Analysis and Statistics B.V  Utrecht the Netherlands"},{"name":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University  Utrecht the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[{"name":"Biogen International GmbH  Baar Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9553-9863","authenticated-orcid":false,"given":"Hans C.","family":"Ebbers","sequence":"additional","affiliation":[{"name":"Biogen International GmbH  Baar Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8361-1954","authenticated-orcid":false,"given":"Cristina","family":"Fernandez\u2010Mendivil","sequence":"additional","affiliation":[{"name":"Biogen International GmbH  Baar Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6479-4757","authenticated-orcid":false,"given":"Marian","family":"Mitroiu","sequence":"additional","affiliation":[{"name":"Biogen International GmbH  Baar Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"International Council of Harmonisation \u201cAddendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials E9(R1).\u201d2019 https:\/\/www.ema.europa.eu\/en\/documents\/scientific\u2010guideline\/ich\u2010e9\u2010r1\u2010addendum\u2010estimands\u2010sensitivity\u2010analysis\u2010clinical\u2010trials\u2010guideline\u2010statistical\u2010principles_en.pdf."},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006\u2010341x.2002.00021.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2018.1489408"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/pst.2104"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/pst.2214"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj\u20102022\u2010070146"},{"key":"e_1_2_8_8_1","unstructured":"National Institute of Arthritis and Musculoskeletal and Skin Diseases \u201cRheumatoid Arthritis. U.S. Department of Health and Human Services National Institutes of Health.\u201d2022 https:\/\/www.niams.nih.gov\/health\u2010topics\/rheumatoid\u2010arthritis."},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2665\u20109913(23)00237\u20100"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380107"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2007.07.011"},{"key":"e_1_2_8_12_1","unstructured":"European Medicines Agency \u201cGuideline on Immunogenicity Assessment of Therapeutic Proteins \u2013 Revision 1.\u201d2017 https:\/\/www.ema.europa.eu\/en\/immunogenicity\u2010assessment\u2010biotechnology\u2010derived\u2010therapeutic\u2010proteins\u2010scientific\u2010guideline."},{"key":"e_1_2_8_13_1","unstructured":"US Food and Drug Administration \u201cGuidance for Industry: Immunogenicity Assessment for Therapeutic Protein Products.\u201d2014 https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/immunogenicity\u2010assessment\u2010therapeutic\u2010protein\u2010products."},{"key":"e_1_2_8_14_1","unstructured":"US Food and Drug Administration \u201cGuidance for Industry: Immunogenicity Testing of Therapeutic Protein Products\u2010Developing and Validating Assays for Anti\u2010Drug Antibody Detection.\u201d2019 https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/immunogenicity\u2010testing\u2010therapeutic\u2010protein\u2010products\u2010developing\u2010and\u2010validating\u2010assays\u2010anti\u2010drug."},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/19466315.2019.1575280"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1201\/9780429488825"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/19466315.2021.2009020"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/pst.2184"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.csda.2007.04.020"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/0962280210395740"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/00491241221113873"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v045.i03"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/rssb.12191"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.9439"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/19466315.2023.2166097"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1515\/1557\u20104679.1380"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.3102\/1076998617719726"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/19466315.2019.1700157"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv135"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/pst.2260"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1986.10478354"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1201\/9780429492259"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.csda.2016.08.012"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.406"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24709"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13495"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket260"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.10.006"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01951"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00312"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.02.068"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1080\/07350015.1988.10509663"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1986.10478280"},{"key":"e_1_2_8_44_1","volume-title":"Classification and Regression Trees","author":"Breiman L.","year":"1984"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq260"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.csda.2013.10.025"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1023\/a:1010933404324"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17077"},{"key":"e_1_2_8_49_1","volume-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin D. B.","year":"2004"},{"key":"e_1_2_8_50_1","doi-asserted-by":"crossref","unstructured":"D.Sabanes Bove J.Dedic D.Kelkhoff et\u00a0al. \u201cMmrm: Mixed Models for Repeated Measures \u201d2022 https:\/\/CRAN.R\u2010project.org\/package=mmrm.","DOI":"10.32614\/CRAN.package.mmrm"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/69.3.635"},{"key":"e_1_2_8_52_1","unstructured":"F. E.Harrell Jr \u201cHmisc: Harrell Miscellaneous \u201d2023 https:\/\/CRAN.R\u2010project.org\/package=Hmisc."},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.201400034"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2021.106494"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.9398"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.2022.2071276"}],"container-title":["Pharmaceutical Statistics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pst.70008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:37:08Z","timestamp":1747741028000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pst.70008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1002\/pst.70008"],"URL":"https:\/\/doi.org\/10.1002\/pst.70008","archive":["Portico"],"relation":{},"ISSN":["1539-1604","1539-1612"],"issn-type":[{"value":"1539-1604","type":"print"},{"value":"1539-1612","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"2024-03-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70008"}}